Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-05T04:45:06.292Z Has data issue: false hasContentIssue false

Off-label use limitation of the Super Arrow-Flex® sheath introducer in congenital heart disease interventions

Published online by Cambridge University Press:  20 August 2021

Raymond N. Haddad*
Affiliation:
Department of Pediatric Cardiology, Hotel Dieu de France University Medical Center, Saint Joseph University, Beirut, Lebanon
Enrico Piccinelli
Affiliation:
Paediatric Cardiology Services, Royal Brompton Hospital and Harefield NHS Foundation Trust, London, UK
Zakhia Saliba
Affiliation:
Department of Pediatric Cardiology, Hotel Dieu de France University Medical Center, Saint Joseph University, Beirut, Lebanon
Alain Fraisse
Affiliation:
Paediatric Cardiology Services, Royal Brompton Hospital and Harefield NHS Foundation Trust, London, UK
*
Author for correspondence: Dr. Raymond N. Haddad, MD, Department of Pediatric Cardiology, Hotel Dieu de France University Medical Center, Saint Joseph University, Alfred Naccache Boulevard, Achrafieh, Beirut, BP 166830, Lebanon. Tel: +961 70 605 800; Fax: +961 1 604 976. E-mail: [email protected]

Abstract

Many interventionists are infatuated by the recent resurgence of the coilwire design with the Super Arrow-Flex® sheath (Teleflex, Inc., NC, United States of America). This exclusive sheath is a highly flexible, durable, conduit intended for use in diagnostic and interventional procedures with several advantages and maximum effectiveness in challenging cases. We report failure to easily advance memory shape occluders through Super Arrow-Flex® sheaths larger than the recommended implant French size. We detail the technical reasons behind this non-previously reported drawback and describe benchside tests as possible solutions.

Type
Brief Report
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Butera, G, Chessa, M, Eicken, A, Thomson, J. Cardiac Catheterization for Congenital Heart Disease: From Fetal Life to Adulthood. Springer-Verlag, Milan, 2015, 10.1007/978-88-470-5681-7.Google Scholar
Hirst, CS, Davila, CD, Garcia, R, Kapur, NK. Transaxillary intra-aortic balloon pump deployment through a novel braided sheath for advanced heart failure patients requiring an extended duration of temporary circulatory support. Cardiovasc Revasc Med 2020; 21: 112115. DOI 10.1016/j.carrev.2020.01.024.CrossRefGoogle ScholarPubMed
Rigatelli, G, Zuin, M, Nghia, NT. Interatrial shunts: technical approaches to percutaneous closure. Expert Rev Med Devices 2018; 15: 707716. DOI 10.1080/17434440.2018.1526674.CrossRefGoogle ScholarPubMed
Butera, G, Lovin, N, Basile, DP. How to deal with atrial septal defect closure from right internal jugular vein: role of venous-arterial circuit for sizing and over-the-wire device implantation. Catheter Cardiovasc Interv 2017; 89: 120123. DOI 10.1002/ccd.26621.CrossRefGoogle ScholarPubMed
Yarrabolu, TR, Robinson, A, Qureshi, AM. A novel technique for percutaneous closure of an atrial septal defect in a patient with interrupted inferior vena cava using a "modified" short sheath from an internal jugular vein approach. Ann Pediatr Cardiol 2017; 10: 102103. DOI 10.4103/0974-2069.197056.CrossRefGoogle Scholar
Gao, M, Li, Z, Zhao, Y, Wen, P. Analysis of the therapeutic effect of transesophageal echocardiography-guided percutaneous device closure of atrial septal defects via the right internal jugular vein in children. Echocardiography 2019; 36: 13571363. DOI 10.1111/echo.14396.CrossRefGoogle ScholarPubMed
Tan, CA, Levi, DS, Moore, JW. Embolization and transcatheter retrieval of coils and devices. Pediatr Cardiol 2005; 26: 267274. DOI 10.1007/s00246-005-1009-1.CrossRefGoogle ScholarPubMed